comparemela.com

Latest Breaking News On - Cancer research laboratory of molecular biology - Page 1 : comparemela.com

Navrogen Enters into CRADA with The U S National Cancer Institute for the Clinical Development of NAV-001, an Anti-Mesothelin Antibody-Drug Conjugate

/PRNewswire/ Navrogen, Inc. announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with researchers at the U.S..

United statesIra pastanNicholas nicolaidesSteven kyriakosLuigi grassoRaffit hassanDevelopment agreementUs national cancer instituteNavrogen incorporatedLaboratory of molecular biologyGi malignancies branchNavrogen incNational institutes of healthCancer research laboratory of molecular biologyCooperative researchCancer institute

Navrogen Enters into CRADA with The U S National Cancer Institute for the Clinical Development of NAV-001, an Anti-Mesothelin Antibody-Drug Conjugate

PHILADELPHIA, Nov. 7, 2022 /PRNewswire/ Navrogen, Inc. announced today that it has entered into a Cooperative Research and Development Agreemen.

United statesIra pastanNicholas nicolaidesSteven kyriakosLuigi grassoRaffit hassanDevelopment agreementUs national cancer instituteNavrogen incorporatedLaboratory of molecular biologyGi malignancies branchNavrogen incNational institutes of healthCancer research laboratory of molecular biologyCooperative researchCancer institute

vimarsana © 2020. All Rights Reserved.